Evaluation of pulmonary infiltrates in patients after stem cell transplantation.
Hematopoietic stem cell transplantation is potentially curative therapy that has become the standard of care for many hematologic malignancies. Pulmonary complications occur in about 50% of stem cell transplant recipients and no other organ dysfunction has a higher mortality. Unfortunately the diagnosis of these infiltrates is hampered by the poor yield from routine studies and this patient population is rarely able to tolerate more risky procedures that will obtain tissue for microscopy and culture. A bronchoalveolar lavage (BAL) is usually insufficient to make a diagnosis of invasive fungal, significant bacterial, or pathogenic viral infections in patients that will still benefit from a change in therapy. In this review we discuss the infectious etiologies of pulmonary infiltrates post hematopoietic stem cell transplant, the non-infectious causes of infiltrates such as diffuse alveolar hemorrhage, engraftment syndrome, and idiopathic pneumonia syndrome, and the yield of newer diagnostic procedures ranging from peripheral blood galactomannan to cytomegalovirus antigenemia, and report on new technologies that promise more accurate and timely diagnoses of these infiltrates.
Scaglione
Steve
S
Internal Medicine Residency Program, Maywood, IL 60153, USA. sscagli@lumc.edu
Hofmeister
Craig C
CC
Stiff
Patrick
P
D018893:Bronchoalveolar Lavage; D006801:Humans; D008171:Lung Diseases / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000821:virology; D033581:Stem Cell Transplantation / Q000009:adverse effects*